21 – 30 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Neutralizing antibodies and efficacy of interferon beta-1a - A 4-year controlled study
(
- Contribution to journal › Article
-
Mark
Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
(
- Contribution to journal › Article
-
Mark
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis The EVIDENCE study.
(
- Contribution to journal › Article
-
Mark
Predicting the Outcome of Optic Neuritis Evaluation of risk factors after 30 years of follow-up.
(
- Contribution to journal › Article
- 2004
-
Mark
No evidence for genetic linkage between development of multiple sclerosis and components of the IFN system and the JAK-STAT pathway.
(
- Contribution to journal › Article
-
Mark
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.
(
- Contribution to journal › Article
- 2003
-
Mark
Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
(
- Contribution to journal › Article
- 2002
-
Mark
International consensus statement on the use of disease-modifying agents in multiple sclerosis
(
- Contribution to journal › Article